164 related articles for article (PubMed ID: 11408921)
1. Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.
Zhang H; Sun XF
Int J Oncol; 2001 Jul; 19(1):49-52. PubMed ID: 11408921
[TBL] [Abstract][Full Text] [Related]
2. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma.
Sun XF
Clin Cancer Res; 2002 Jan; 8(1):165-70. PubMed ID: 11801554
[TBL] [Abstract][Full Text] [Related]
3. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
[TBL] [Abstract][Full Text] [Related]
4. SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer.
Zhang H; Widegren E; Wang DW; Sun XF
Tumour Biol; 2011 Dec; 32(6):1225-31. PubMed ID: 21887554
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
6. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.
Thomas GV; Szigeti K; Murphy M; Draetta G; Pagano M; Loda M
Am J Pathol; 1998 Sep; 153(3):681-7. PubMed ID: 9736017
[TBL] [Abstract][Full Text] [Related]
8. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; Romano C; Vollaro M; Agostini B; Pignatelli C; De Vita F
Dis Colon Rectum; 2004 Nov; 47(11):1904-14. PubMed ID: 15622584
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells.
Zhang H; Schneider J; Rosdahl I
Int J Oncol; 2002 Jul; 21(1):43-8. PubMed ID: 12063548
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
[TBL] [Abstract][Full Text] [Related]
13. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC
Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
[TBL] [Abstract][Full Text] [Related]
15. Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma.
Noura S; Yamamoto H; Sekimoto M; Takemasa I; Miyake Y; Ikenaga M; Matsuura N; Monden M
Int J Oncol; 2001 Jul; 19(1):39-47. PubMed ID: 11408920
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.
Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y
Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730
[TBL] [Abstract][Full Text] [Related]
19. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]